A Rare Court Ruling Allowed the Drug Maker Fresenius to Nix a $4.75 Billion Deal
A judge agreed that Akorn had made misrepresentations about its business that were serious enough for Fresenius to walk out on a buyout.
x
A Rare Court Ruling Allowed the Drug Maker Fresenius to Nix a $4.75 Billion Deal
A judge agreed that Akorn had made misrepresentations about its business that were serious enough for Fresenius to walk out on a buyout.